Thomas Colarusso

Thomas Colarusso

Co-founder & CEO

Bio-AI Health

A veteran business executive with 20 years’ experience who has a proven track record in developing life sciences and diagnostics businesses. He has held commercial leadership positions at companies including Definiens, PathAI & HalioDx. He was a key member of the Definiens commercial leadership team who build the tissue biomarker services business and subsequently sold the company to AstraZeneca Medimmune for $150m upfront payment + milestones in Nov 2014.

Thomas has extensive experience in developing technology platform businesses used to help improve and accelerate biomarker development, anatomical pathology, clinical trials and companion diagnostics assays used to aid patient selection for novel drug targeted therapy programs.

Other speakers in 2020

Аli Pirzada


Аli Pirzada, MD

Head of Forensic and Integrity Services in Bulgaria, N. Macedonia, Albania and Kosovo
Radka Kaneva


Prof. Radka Kaneva, PhD

Executive Manager of Molecular Medicine Center at Medical University of Sofia
Member of BAPEMED Executive Board
Liliya Evtimova-Tichev

Bulgaria, The Netherlands

Liliya Evtimova-Tichev

Validation/Qualification Engineer for Quality Assurance
Lonza, Netherlands
Skip to content